Back to search

Article

Plasmodium falciparum Histo-Aspartic Protease (HAP) inhibitor: Toxicity Investigation and Docking Study of 2-(2-benzoyl-4-methylphenoxy)quinoline-3-carbaldehyde derivatives

2023-03-30

Abstract excerpt

<title>Abstract</title> <p>Aspartic proteases possess catalytic sites for hydrolysis of peptide bonds which makes them potentials drug target in the malaria parasites. Inhibiting Histo-Aspartic Protease (HAP), aspartate (Asp<sub>215</sub>) and histidine (His<sub>32</sub>) residues of the <italic>P. falciparum</italic> disrupts the growth phase and ability to catalyse erythrocyte hemoglobin degradation. We synthes...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
94b4a39a-a08c-5cc9-8a01-ad0f3695fda2
DOI
10.21203/rs.3.rs-2748975/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Plasmodium falciparum Histo-Aspartic Protease (HAP) inhibitor: Toxicity Investigation and Docking Study of 2-(2-benzoyl-4-methylphenoxy)quinoline-3-carbaldehyde derivativesDOI 10.21203/rs.3.rs-2748975/v1
Select a neighboring publication to make it the new centre.